Trade Summary

2 months ago, Afeyan Noubar, serving as Dir, 10% owner at Generate Biomedicines, Inc. (GENB), purchased 4,687,500 shares at $16.00 per share, for a total transaction value of $75,000,000.00. Following this transaction, Afeyan Noubar now holds 62,673,117 shares of GENB.

This purchase represents a 8.00% increase in Afeyan Noubar's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, March 2, 2026 and publicly disclosed via SEC Form 4 filing on Monday, March 2, 2026, meaning the disclosure happened on the same day as the trade.

Generate Biomedicines, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.